Growth Metrics

Regeneron Pharmaceuticals (REGN) Share-based Compensation (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.25%
Dec 31, 2025 5.19%
Sep 30, 2025 -5.84%
Jun 30, 2025 -1.56%
Mar 31, 2025 -16.00%
Dec 31, 2024 35.23%
Sep 30, 2024 0.85%
Jun 30, 2024 -3.00%
Mar 31, 2024 -4.28%
Dec 31, 2023 17.90%
Sep 30, 2023 0.94%
Jun 30, 2023 -15.37%
Mar 31, 2023 2.89%
Dec 31, 2022 39.51%
Sep 30, 2022 4.07%
Jun 30, 2022 -4.25%
Mar 31, 2022 -11.41%
Dec 31, 2021 37.62%
Sep 30, 2021 -5.91%
Jun 30, 2021 11.15%
Mar 31, 2021 7.74%
Dec 31, 2020 20.06%
Sep 30, 2020 -2.22%
Jun 30, 2020 -2.17%
Mar 31, 2020 -20.75%
Dec 31, 2019 14.01%
Sep 30, 2019 10.68%
Jun 30, 2019 -1.95%
Mar 31, 2019 -14.84%
Dec 31, 2018 13.63%
Sep 30, 2018 4.40%
Jun 30, 2018 29.61%
Mar 31, 2018 -35.20%
Dec 31, 2017 1.65%
Sep 30, 2017 3.17%
Jun 30, 2017 -9.37%
Mar 31, 2017 -13.45%
Dec 31, 2016 17.66%
Sep 30, 2016 -0.24%
Jun 30, 2016 -7.42%
Mar 31, 2016 -10.19%
Dec 31, 2015 54.38%
Sep 30, 2015 8.85%
Jun 30, 2015 -9.16%
Mar 31, 2015 -8.19%
Dec 31, 2014 65.96%
Sep 30, 2014 5.05%
Jun 30, 2014 -14.46%
Mar 31, 2014 5.02%
Dec 31, 2013 57.75%
Sep 30, 2013 2.93%
Jun 30, 2013 -16.19%
Mar 31, 2013 72.33%
Dec 31, 2012 49.85%
Sep 30, 2012 4.74%
Jun 30, 2012 -15.65%
Mar 31, 2012 49.64%
Dec 31, 2011 16.23%
Sep 30, 2011 7.81%
Jun 30, 2011 -16.25%
Mar 31, 2011 9.10%
Dec 31, 2010 54.33%
Sep 30, 2010 0.95%
Jun 30, 2010 -1.44%
Mar 31, 2010 2.04%
Dec 31, 2009 15.30%